![Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial | Cardio-Oncology | Full Text Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial | Cardio-Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40959-021-00115-w/MediaObjects/40959_2021_115_Fig1_HTML.png)
Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial | Cardio-Oncology | Full Text
![Sanah Christopher on Twitter: "PRADA trial #ACC21 long-term👀 for 💊Metoprolol/Candesartan vs placebo in breast cancer adjuvant therapy ⭐️2yr follow up 🚫difference in EF⬇️ for Metoprolol/Candesartan vs placebo (EF ⬇️ low at baseline) Sanah Christopher on Twitter: "PRADA trial #ACC21 long-term👀 for 💊Metoprolol/Candesartan vs placebo in breast cancer adjuvant therapy ⭐️2yr follow up 🚫difference in EF⬇️ for Metoprolol/Candesartan vs placebo (EF ⬇️ low at baseline)](https://pbs.twimg.com/media/E1gxLTUVIAQ3fqE.jpg)
Sanah Christopher on Twitter: "PRADA trial #ACC21 long-term👀 for 💊Metoprolol/Candesartan vs placebo in breast cancer adjuvant therapy ⭐️2yr follow up 🚫difference in EF⬇️ for Metoprolol/Candesartan vs placebo (EF ⬇️ low at baseline)
![Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy ( PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol | Circulation Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy ( PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol | Circulation](https://www.ahajournals.org/cms/asset/02c15eb9-4540-4421-90b1-846feb79107c/circulationaha.121.054698.fig01.gif)
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy ( PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol | Circulation
![Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study - The Lancet Oncology Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/7fb84603-13eb-4ad1-8525-4250c9df1d5f/gr2_lrg.jpg)
Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study - The Lancet Oncology
![Geeta Gulati 1, Siri Lagethon Heck 1, Anne Hansen Ree 1, Pavel Hoffmann 2, Jeanette Schulz-Menger 3, Morten W Fagerland 2, Berit Gravdehaug 1, Florian. - ppt download Geeta Gulati 1, Siri Lagethon Heck 1, Anne Hansen Ree 1, Pavel Hoffmann 2, Jeanette Schulz-Menger 3, Morten W Fagerland 2, Berit Gravdehaug 1, Florian. - ppt download](https://images.slideplayer.com/27/8955914/slides/slide_5.jpg)
Geeta Gulati 1, Siri Lagethon Heck 1, Anne Hansen Ree 1, Pavel Hoffmann 2, Jeanette Schulz-Menger 3, Morten W Fagerland 2, Berit Gravdehaug 1, Florian. - ppt download
Prevention of cardiac dysfunction during adjuvant breast cancer therapy ( PRADA): a 2 3 2 factorial, randomized, placebo-controll
Prada Receive a Complimentary 4-Pc. trial set with any large spray purchase from the Prada Candy fragrance collection & Reviews - Shop All Brands - Beauty - Macy's
![PDF] Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial | Semantic Scholar PDF] Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fbd375114c38c6feaefa42552dfdf20cb0070dd0/5-Figure1-1.png)
PDF] Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial | Semantic Scholar
![PRADA Trial: Candesartan or Metoprolol for Preventing Cardiac Dysfunction During Adjuvant Breast Cancer Therapy | tctmd.com PRADA Trial: Candesartan or Metoprolol for Preventing Cardiac Dysfunction During Adjuvant Breast Cancer Therapy | tctmd.com](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/5270290550001/a6fca177-b428-4756-be4f-d5c7ee817966/main/1280x720/9m15s61ms/match/image.jpg)
PRADA Trial: Candesartan or Metoprolol for Preventing Cardiac Dysfunction During Adjuvant Breast Cancer Therapy | tctmd.com
![Diego Segura-Rodriguez on Twitter: "📌Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (#PRADA) 🔸#Candesartan & #metoprolol during adjuvant therapy did not prevent decline in #LVEF 🔸 Not supporting broadly administered ... Diego Segura-Rodriguez on Twitter: "📌Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (#PRADA) 🔸#Candesartan & #metoprolol during adjuvant therapy did not prevent decline in #LVEF 🔸 Not supporting broadly administered ...](https://pbs.twimg.com/media/E3wIBStXoAUKuLP.jpg)
Diego Segura-Rodriguez on Twitter: "📌Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (#PRADA) 🔸#Candesartan & #metoprolol during adjuvant therapy did not prevent decline in #LVEF 🔸 Not supporting broadly administered ...
![Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study - The Lancet Oncology Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study - The Lancet Oncology](https://www.thelancet.com/cms/asset/53376ae2-bdd3-4d55-810a-dfa3ffdc74f9/gr1.jpg)